6Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: rationale, clinieopathological correlations, and classification[ J]. Kidney Int ,2009,76(5 ) :477 - 480.
7Reich HN, Troyanov S, Scholey JW, et al. Remission of proteinuria improves prognosis in IgA nephropathy [ J ]. J Am Soc Nephrol, 2007,18(12) :3177 - 3183.
8Praga M, Gutierrez E, Gonzalez E, et al. Treatment of IgA nephrop- athy with ACE inhibitors:a randomized and controlled trial [ J]. J Am Soc Nephrol,2003,14 (6) : 1578 - 1583.
9Coppo R, Peruzzi L, Amore A, et al. IgACE : a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria [ J ]. J Am Soc Nephrol,2007,18 ( 6 ) : 1880 - 1888.
10Li PK,Leung CB ,Chow KM,et al. Hong Kong study using valsar- tan in IgA nephropathy (HKVIN) : a double-blind, randomized, placebo-controlled study [ J ]. Am J Kidney Dis, 2006,47 ( 5 ) : 751 - 760.
